Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
61
KELYA Quote, Financials, Valuation and Earnings
Last price:
$12.54
Seasonality move
:
-0.53%
Day range:
$11.97 - $12.35
52-week range:
$10.80 - $23.81
Dividend yield:
2.44%
P/E ratio:
12.39x
P/S ratio:
0.10x
P/B ratio:
0.35x
Volume:
414.3K
Avg. volume:
269K
1-year change:
-44.92%
Market cap:
$433M
Revenue:
$4.3B
EPS (TTM):
-$0.60
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.9B | $5B | $4.8B | $4.3B | |
| Revenue Growth (YoY) | -15.68% | 8.72% | 1.14% | -2.61% | -10.42% | |
| Cost of Revenues | $3.7B | $4B | $4B | $3.9B | $3.4B | |
| Gross Profit | $827.6M | $919.2M | $1B | $961.4M | $882.6M | |
| Gross Profit Margin | 18.33% | 18.72% | 20.38% | 19.88% | 20.38% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $805.6M | $870.6M | $943.5M | $934.7M | $818.4M | |
| Other Inc / (Exp) | -$126.4M | $139.5M | -$139.7M | -$5.3M | -$82M | |
| Operating Expenses | $805.6M | $870.6M | $943.5M | $934.7M | $818.4M | |
| Operating Income | $22M | $48.6M | $68.3M | $26.7M | $64.2M | |
| Net Interest Expenses | $2.4M | $2.3M | -- | -- | $4.1M | |
| EBT. Incl. Unusual Items | -$106.8M | $185.8M | -$71.2M | $24.9M | -$21.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$34M | $35.1M | -$7.9M | -$11.5M | -$21.3M | |
| Net Income to Company | -$72M | $156.1M | -$62.5M | $36.4M | -$600K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$72M | $156.1M | -$62.5M | $36.4M | -$600K | |
| Basic EPS (Cont. Ops) | -$1.83 | $3.93 | -$1.64 | $0.99 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -$1.83 | $3.91 | -$1.64 | $0.98 | -$0.02 | |
| Weighted Average Basic Share | $39.3M | $39.4M | $38.1M | $35.9M | $35.5M | |
| Weighted Average Diluted Share | $39.3M | $39.5M | $38.1M | $36.3M | $35.5M | |
| EBITDA | -$58.5M | $239.3M | -$17.2M | $78.2M | $39.9M | |
| EBIT | -$103.8M | $188.3M | -$69.1M | $28.1M | -$11M | |
| Revenue (Reported) | $4.5B | $4.9B | $5B | $4.8B | $4.3B | |
| Operating Income (Reported) | $22M | $48.6M | $68.3M | $26.7M | $64.2M | |
| Operating Income (Adjusted) | -$103.8M | $188.3M | -$69.1M | $28.1M | -$11M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.3B | $1B | $1.2B | |
| Revenue Growth (YoY) | -4.38% | 7.51% | -2.17% | -17.6% | 11.46% | |
| Cost of Revenues | $992.6M | $1B | $1B | $839.4M | $928.4M | |
| Gross Profit | $213.3M | $258.6M | $254.1M | $205.7M | $236.5M | |
| Gross Profit Margin | 17.69% | 19.95% | 20.04% | 19.68% | 20.3% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $202.7M | $236.1M | $243.4M | $190.5M | $225.7M | |
| Other Inc / (Exp) | $27.1M | -$83.4M | $1.4M | $12.3M | -- | |
| Operating Expenses | $202.7M | $236.1M | $243.4M | $190.5M | $225.7M | |
| Operating Income | $10.6M | $22.5M | $10.7M | $15.2M | $10.8M | |
| Net Interest Expenses | $500K | $500K | -- | -- | $3.2M | |
| EBT. Incl. Unusual Items | $37.2M | -$61.4M | $12.7M | $29.8M | $7.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10.5M | -$13M | $1.8M | $4M | $1.8M | |
| Net Income to Company | $25.6M | -$47.6M | $10.9M | $25.8M | $5.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $25.6M | -$47.6M | $10.9M | $25.8M | $5.8M | |
| Basic EPS (Cont. Ops) | $0.65 | -$1.23 | $0.29 | $0.71 | $0.16 | |
| Diluted EPS (Cont. Ops) | $0.64 | -$1.23 | $0.29 | $0.70 | $0.16 | |
| Weighted Average Basic Share | $39.3M | $38.6M | $37.1M | $35.4M | $35M | |
| Weighted Average Diluted Share | $39.5M | $38.6M | $37.4M | $35.8M | $35.5M | |
| EBITDA | $48.9M | -$48.3M | $26.2M | $40.5M | $25.2M | |
| EBIT | $37.8M | -$60.8M | $13.5M | $30.3M | $11.6M | |
| Revenue (Reported) | $1.2B | $1.3B | $1.3B | $1B | $1.2B | |
| Operating Income (Reported) | $10.6M | $22.5M | $10.7M | $15.2M | $10.8M | |
| Operating Income (Adjusted) | $37.8M | -$60.8M | $13.5M | $30.3M | $11.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $5B | $4.9B | $4.6B | $4.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.6B | $4B | $3.9B | $3.7B | $3.5B | |
| Gross Profit | $817.6M | $964.5M | $1B | $913M | $913.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $788.8M | $904M | $950.8M | $881.8M | $853.6M | |
| Other Inc / (Exp) | $91.8M | $29M | -$54.9M | $5.6M | -$94.3M | |
| Operating Expenses | $788.8M | $904M | $950.8M | $881.8M | $853.6M | |
| Operating Income | $28.8M | $60.5M | $56.5M | $31.2M | $59.8M | |
| Net Interest Expenses | $2.3M | $2.3M | -- | -- | $9.6M | |
| EBT. Incl. Unusual Items | $118.3M | $87.2M | $2.9M | $42M | -$44.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12.7M | $11.6M | $6.9M | -$9.3M | -$23.5M | |
| Net Income to Company | $106.8M | $82.9M | -$4M | $51.3M | -$20.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $106.8M | $82.9M | -$4M | $51.3M | -$20.6M | |
| Basic EPS (Cont. Ops) | $2.70 | $2.04 | -$0.10 | $1.41 | -$0.59 | |
| Diluted EPS (Cont. Ops) | $2.69 | $2.04 | -$0.10 | $1.39 | -$0.60 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $166.1M | $142.1M | $57.3M | $92.5M | $24.6M | |
| EBIT | $121M | $89.7M | $5.2M | $44.9M | -$29.7M | |
| Revenue (Reported) | $4.5B | $5B | $4.9B | $4.6B | $4.5B | |
| Operating Income (Reported) | $28.8M | $60.5M | $56.5M | $31.2M | $59.8M | |
| Operating Income (Adjusted) | $121M | $89.7M | $5.2M | $44.9M | -$29.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.3B | $1B | $1.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $992.6M | $1B | $1B | $839.4M | $928.4M | |
| Gross Profit | $213.3M | $258.6M | $254.1M | $205.7M | $236.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $202.7M | $236.1M | $243.4M | $190.5M | $225.7M | |
| Other Inc / (Exp) | $27.1M | -$83.4M | $1.4M | $12.3M | -- | |
| Operating Expenses | $202.7M | $236.1M | $243.4M | $190.5M | $225.7M | |
| Operating Income | $10.6M | $22.5M | $10.7M | $15.2M | $10.8M | |
| Net Interest Expenses | $500K | $500K | -- | -- | $3.2M | |
| EBT. Incl. Unusual Items | $37.2M | -$61.4M | $12.7M | $29.8M | $7.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10.5M | -$13M | $1.8M | $4M | $1.8M | |
| Net Income to Company | $25.6M | -$47.6M | $10.9M | $25.8M | $5.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $25.6M | -$47.6M | $10.9M | $25.8M | $5.8M | |
| Basic EPS (Cont. Ops) | $0.65 | -$1.23 | $0.29 | $0.71 | $0.16 | |
| Diluted EPS (Cont. Ops) | $0.64 | -$1.23 | $0.29 | $0.70 | $0.16 | |
| Weighted Average Basic Share | $39.3M | $38.6M | $37.1M | $35.4M | $35M | |
| Weighted Average Diluted Share | $39.5M | $38.6M | $37.4M | $35.8M | $35.5M | |
| EBITDA | $48.9M | -$48.3M | $26.2M | $40.5M | $25.2M | |
| EBIT | $37.8M | -$60.8M | $13.5M | $30.3M | $11.6M | |
| Revenue (Reported) | $1.2B | $1.3B | $1.3B | $1B | $1.2B | |
| Operating Income (Reported) | $10.6M | $22.5M | $10.7M | $15.2M | $10.8M | |
| Operating Income (Adjusted) | $37.8M | -$60.8M | $13.5M | $30.3M | $11.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $223M | $112.7M | $153.7M | $125.8M | $39M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.3B | $1.4B | $1.5B | $1.2B | $1.3B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $61.4M | $52.8M | $69.9M | $48.9M | $71M | |
| Total Current Assets | $1.5B | $1.6B | $1.7B | $1.6B | $1.4B | |
| Property Plant And Equipment | $124.2M | $111.1M | $94.6M | $71.6M | $72.8M | |
| Long-Term Investments | $282.7M | $387.7M | -- | -- | $11M | |
| Goodwill | $3.5M | $114.8M | $151.1M | $151.1M | $304.2M | |
| Other Intangibles | $55.6M | $132.7M | $172.4M | $137.7M | $274.2M | |
| Other Long-Term Assets | $35.5M | $18M | $24.4M | $43.2M | $11.5M | |
| Total Assets | $2.6B | $2.9B | $2.7B | $2.6B | $2.6B | |
| Accounts Payable | $536.8M | $687.2M | $723.3M | $646.1M | $613.8M | |
| Accrued Expenses | $293M | $318.4M | $315.8M | $156.2M | $163.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $19.6M | $17.5M | $14.7M | $8.4M | $12.3M | |
| Other Current Liabilities | -- | -- | -- | $169.9M | -- | |
| Total Current Liabilities | $925.6M | $1.1B | $1.1B | $1B | $826.5M | |
| Long-Term Debt | -- | -- | -- | -- | $239.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.4B | $1.6B | $1.4B | $1.3B | $1.4B | |
| Common Stock | $40.1M | $40.1M | $38.5M | $38.5M | $38.5M | |
| Other Common Equity Adj | -$4.2M | -$27.7M | -$8.5M | $200K | -$6.9M | |
| Common Equity | $1.2B | $1.3B | $1.3B | $1.3B | $1.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.2B | $1.3B | $1.3B | $1.3B | $1.2B | |
| Total Liabilities and Equity | $2.6B | $2.9B | $2.7B | $2.6B | $2.6B | |
| Cash and Short Terms | $223M | $112.7M | $153.7M | $125.8M | $39M | |
| Total Debt | $300K | -- | $700K | -- | $239.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $239.4M | $230.3M | $111.7M | $200.7M | $28.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.3B | $1.5B | $1.4B | $1.2B | $1.3B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $76.5M | $72.2M | $82.3M | $83.2M | $71.9M | |
| Total Current Assets | $1.6B | $1.8B | $1.6B | $1.4B | $1.4B | |
| Property Plant And Equipment | $117.9M | $103.8M | $93.6M | $71.8M | $69.6M | |
| Long-Term Investments | $300.4M | -- | -- | -- | -- | |
| Goodwill | $3.5M | $155.8M | $151.1M | $151.1M | $304.1M | |
| Other Intangibles | -- | -- | -- | $132.5M | $248.4M | |
| Other Long-Term Assets | $306.3M | $396.1M | $409.5M | $40.6M | $36.9M | |
| Total Assets | $2.6B | $2.8B | $2.6B | $2.4B | $2.6B | |
| Accounts Payable | $554.3M | $711.6M | $684.7M | $581.2M | $597M | |
| Accrued Expenses | $309.9M | $338.9M | $275.9M | $165.9M | $178.7M | |
| Current Portion Of Long-Term Debt | $1.1M | $200K | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $18.8M | $16.1M | $14.3M | $8.4M | $12.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $962.9M | $1.2B | $1.1B | $797.5M | $822.9M | |
| Long-Term Debt | -- | -- | -- | -- | $204.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.4B | $1.5B | $1.3B | $1.1B | $1.4B | |
| Common Stock | $40.1M | $38.5M | $38.5M | $38.5M | $38.5M | |
| Other Common Equity Adj | -$17.8M | -$14.7M | -$6.2M | -$500K | -$5.6M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.2B | $1.3B | $1.2B | $1.3B | $1.2B | |
| Total Liabilities and Equity | $2.6B | $2.8B | $2.6B | $2.4B | $2.6B | |
| Cash and Short Terms | $239.4M | $230.3M | $111.7M | $200.7M | $28.2M | |
| Total Debt | $1.1M | $200K | -- | -- | $204.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$72M | $156.1M | -$62.5M | $36.4M | -$600K | |
| Depreciation & Amoritzation | $45.3M | $51M | $51.9M | $50.1M | $50.9M | |
| Stock-Based Compensation | $3.9M | $5.1M | $7.8M | $9.7M | $11.8M | |
| Change in Accounts Receivable | $55.9M | -$150.7M | -$99.3M | $147.2M | -$20.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $186M | $85M | -$76.3M | $76.7M | $26.9M | |
| Capital Expenditures | $15.5M | $11.2M | $12M | $15.3M | $11.1M | |
| Cash Acquisitions | -$38M | -$213M | $167.3M | -- | -$354.8M | |
| Cash From Investing | $9.8M | -$180.7M | $167.5M | -$14.1M | -$361.6M | |
| Dividends Paid (Ex Special Dividend) | -$3M | -$4M | -$10.6M | -$11M | -$10.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $1.3B | |
| Long-Term Debt Repaid | -$2M | -$1.5M | -$1.4M | -$1.2M | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -$35M | -$42.2M | -$10M | |
| Other Financing Activities | -$1.4M | -$2.4M | -$4.4M | -$4.5M | -$3.7M | |
| Cash From Financing | -$8.1M | -$8.1M | -$50.6M | -$59.6M | $214.8M | |
| Beginning Cash (CF) | $31M | $228.1M | $119.5M | $162.4M | $167.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $187.7M | -$103.8M | $40.6M | $3M | -$119.9M | |
| Ending Cash (CF) | $228.1M | $119.5M | $162.4M | $167.6M | $45.6M | |
| Levered Free Cash Flow | $170.5M | $73.8M | -$88.3M | $61.4M | $15.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $25.6M | -$47.6M | $10.9M | $25.8M | $5.8M | |
| Depreciation & Amoritzation | $11.1M | $12.5M | $12.7M | $10.2M | $13.6M | |
| Stock-Based Compensation | $1.4M | $2.1M | $3.1M | $2.8M | $3.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.5M | -$106.1M | -$13.5M | -$25.5M | $23.9M | |
| Capital Expenditures | $2.7M | $1.7M | $4.4M | $3.7M | $2.5M | |
| Cash Acquisitions | -- | $258.1M | -- | $77.1M | $6.4M | |
| Cash From Investing | $7.9M | $257.1M | -$2.2M | $72.1M | $3.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -$1.9M | -$2.8M | -$2.7M | -$2.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $412.3M | |
| Long-Term Debt Repaid | -$200K | -$300K | -$400K | -- | -$447.1M | |
| Repurchase of Common Stock | -- | -$27.2M | -$18.3M | -- | -- | |
| Other Financing Activities | -$500K | -$1.5M | -$2.6M | -$2M | -$1.9M | |
| Cash From Financing | $100K | -$30.7M | -$24.8M | -$4.7M | -$39.5M | |
| Beginning Cash (CF) | $228.1M | $119.5M | $162.4M | $167.6M | $45.6M | |
| Foreign Exchange Rate Adjustment | -$1.4M | -$1.7M | -$800K | -$600K | $1.3M | |
| Additions / Reductions | $18.5M | $120.3M | -$40.5M | $41.9M | -$12.4M | |
| Ending Cash (CF) | $245.2M | $238.1M | $121.1M | $208.9M | $34.5M | |
| Levered Free Cash Flow | $7.8M | -$107.8M | -$17.9M | -$29.2M | $21.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $106.8M | $82.9M | -$4M | $51.3M | -$20.6M | |
| Depreciation & Amoritzation | $45.1M | $52.4M | $52.1M | $47.6M | $54.3M | |
| Stock-Based Compensation | $4.1M | $5.8M | $8.8M | $9.4M | $12.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $188.1M | -$31.6M | $16.3M | $64.7M | $76.3M | |
| Capital Expenditures | $15.2M | $10.2M | $14.7M | $14.6M | $9.9M | |
| Cash Acquisitions | -$1.7M | $45.1M | -$90.8M | $77.1M | -$425.5M | |
| Cash From Investing | $1.8M | $68.5M | -$91.8M | $60.2M | -$430.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -$5.9M | -$11.5M | -$10.9M | -$11M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $1.8B | |
| Long-Term Debt Repaid | -$1.9M | -$1.6M | -$1.5M | -$800K | -$1.5B | |
| Repurchase of Common Stock | -- | -$27.2M | -$26.1M | -$23.9M | -- | |
| Other Financing Activities | -$700K | -$3.4M | -$5.5M | -$3.9M | -$3.6M | |
| Cash From Financing | -$3.4M | -$38.9M | -$44.7M | -$39.5M | $180M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $186.5M | -$2M | -$120.2M | $85.4M | -$174.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $172.9M | -$41.8M | $1.6M | $50.1M | $66.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $25.6M | -$47.6M | $10.9M | $25.8M | $5.8M | |
| Depreciation & Amoritzation | $11.1M | $12.5M | $12.7M | $10.2M | $13.6M | |
| Stock-Based Compensation | $1.4M | $2.1M | $3.1M | $2.8M | $3.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.5M | -$106.1M | -$13.5M | -$25.5M | $23.9M | |
| Capital Expenditures | $2.7M | $1.7M | $4.4M | $3.7M | $2.5M | |
| Cash Acquisitions | -- | $258.1M | -- | $77.1M | $6.4M | |
| Cash From Investing | $7.9M | $257.1M | -$2.2M | $72.1M | $3.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -$1.9M | -$2.8M | -$2.7M | -$2.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $412.3M | |
| Long-Term Debt Repaid | -$200K | -$300K | -$400K | -- | -$447.1M | |
| Repurchase of Common Stock | -- | -$27.2M | -$18.3M | -- | -- | |
| Other Financing Activities | -$500K | -$1.5M | -$2.6M | -$2M | -$1.9M | |
| Cash From Financing | $100K | -$30.7M | -$24.8M | -$4.7M | -$39.5M | |
| Beginning Cash (CF) | $228.1M | $119.5M | $162.4M | $167.6M | $45.6M | |
| Foreign Exchange Rate Adjustment | -$1.4M | -$1.7M | -$800K | -$600K | $1.3M | |
| Additions / Reductions | $18.5M | $120.3M | -$40.5M | $41.9M | -$12.4M | |
| Ending Cash (CF) | $245.2M | $238.1M | $121.1M | $208.9M | $34.5M | |
| Levered Free Cash Flow | $7.8M | -$107.8M | -$17.9M | -$29.2M | $21.4M | |
Get KELYA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KELYA
Sector
P/E ratio
12.39x
18.58x
PEG ratio
0.16x
0.25x
P/B ratio
0.35x
1.75x
Price / LTM sales
0.10x
0.94x
Growth Metrics
KELYA
Sector
Revenue growth
11.46%
1.98%
Earnings growth
-77.14%
2.46%
Revenue (5-year growth)
-4.15%
4.35%
Earnings forecast
$0.55
$0.40
Profitability
KELYA
Sector
Profitability FY 2024
$882.6M
$393.9M
Return on invested capital
-1.43%
5.32%
Return on assets
-0.8%
3.49%
Return on equity
-1.63%
8.55%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
7
Balance Sheet
KELYA
Sector
Total cash
$28.2M
$154.3M
Short term investments
--
$35.5M
Total assets
$2.6B
$1.7B
Long term debt
$204.6M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
